Therefore, laminin may also serve as a potential therapeutic target for sarcopenia associated with T2DM, operating primarily through its interactions with integrin receptors to activate key signaling pathways that support the proliferation, migration, and differentiation of muscle satellite cells. Here, LAMB2 is linked to sarcopenia.